BE900856A - Compositions pour combattre la toxemie. - Google Patents

Compositions pour combattre la toxemie.

Info

Publication number
BE900856A
BE900856A BE0/213859A BE213859A BE900856A BE 900856 A BE900856 A BE 900856A BE 0/213859 A BE0/213859 A BE 0/213859A BE 213859 A BE213859 A BE 213859A BE 900856 A BE900856 A BE 900856A
Authority
BE
Belgium
Prior art keywords
combating
compositions
toxemia
compounds
represent
Prior art date
Application number
BE0/213859A
Other languages
English (en)
Original Assignee
Geistlich Soehne Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Geistlich Soehne Ag filed Critical Geistlich Soehne Ag
Publication of BE900856A publication Critical patent/BE900856A/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/02—Antidotes
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D285/00—Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups C07D275/00 - C07D283/00
    • C07D285/15—Six-membered rings
    • C07D285/16—Thiadiazines; Hydrogenated thiadiazines
    • C07D285/18—1,2,4-Thiadiazines; Hydrogenated 1,2,4-thiadiazines
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Toxicology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Peptides Or Proteins (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)

Abstract

L'invention concerne des composés de la formule (I) dans laquelle R1 et R2 représentent chacun un atome d'hydrogène ou un radical alkyle en C1 à C6 et R2 peut également représenter un radical de la formule (II) dans laquelle R est tel que défini précédemment, ainsi que les compositions pharmaceutiques qui contiennent ces composés pour combattre des peptides ou des protéines toxiques, par exemple des venins, des toxines fongiques et des exotoxines bactériennes dans la circulation sanguine.
BE0/213859A 1983-10-20 1984-10-19 Compositions pour combattre la toxemie. BE900856A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB838328111A GB8328111D0 (en) 1983-10-20 1983-10-20 Chemical compounds

Publications (1)

Publication Number Publication Date
BE900856A true BE900856A (fr) 1985-02-15

Family

ID=10550511

Family Applications (1)

Application Number Title Priority Date Filing Date
BE0/213859A BE900856A (fr) 1983-10-20 1984-10-19 Compositions pour combattre la toxemie.

Country Status (10)

Country Link
US (1) US4626536A (fr)
EP (1) EP0139535B1 (fr)
JP (1) JPS60105618A (fr)
AT (1) ATE59296T1 (fr)
AU (1) AU3457384A (fr)
BE (1) BE900856A (fr)
CH (1) CH660970A5 (fr)
DE (2) DE3483869D1 (fr)
GB (1) GB8328111D0 (fr)
IT (1) IT1178154B (fr)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8617482D0 (en) * 1986-07-17 1986-08-28 Geistlich Soehne Ag Pharmaceutical composition
US5210083A (en) * 1986-07-17 1993-05-11 Ed. Geistlich Sohne A.G. Fur Chemische Industrie Pharmaceutical compositions
GB9005856D0 (en) * 1990-03-15 1990-05-09 Geistlich Soehne Ag Compositions
GB9600426D0 (en) * 1996-01-10 1996-03-13 Ed Geistlich Sohne A G Compositions
US6479481B1 (en) * 1999-06-04 2002-11-12 Ed. Geistlich Soehne Ag Fur Chemische Industrie Methods and compositions for treating primary and secondary tumors of the central nervous system (CNS)
US8304390B2 (en) * 1997-07-31 2012-11-06 Ed. Geistlich Soehne Ag Fuer Chemische Industrie Method of treatment for preventing or reducing tumor growth in the liver of patient
US20060199811A1 (en) * 1997-07-31 2006-09-07 Pfirrmann Rolf W Method of treatment for preventing or reducing tumor growth in the liver of patient
US20050124608A1 (en) * 2001-04-03 2005-06-09 Redmond H. P. Treatment of cancers
US6011030A (en) * 1997-09-22 2000-01-04 Ed. Geistlich Sohne Ag Fur Chemische Industrie Method of treating symptoms of microbial infection or sepsis
US5972933A (en) * 1998-01-08 1999-10-26 Ed. Geistlich Sohne Ag Fur Chemische Industrie Method of treating microbial infections
US6166007A (en) 1998-07-02 2000-12-26 Sodemann; Klaus Antimicrobial locks comprising taurinamide derivatives and carboxylic acids and/or salts thereof
US6821968B2 (en) * 2001-09-26 2004-11-23 Ed. Geistlich Soehne Ag Fuer Chemische Industrie Stable taurolidine electrolyte solutions
US7892530B2 (en) 1999-06-04 2011-02-22 Ed. Geistlich Soehne Ag Fuer Chemische Industrie Treatment of tumor metastases and cancer
US8030301B2 (en) 1999-06-04 2011-10-04 Ed. Geistlich Soehne Ag Fuer Chemische Industrie Treatment of cancers with methylol-containing compounds and at least one electrolyte
US7345039B2 (en) * 1999-06-04 2008-03-18 Ed. Geistlich Soehne Ag Fuer Chemische Industrie Enhancement of effectiveness of 5-fluorouracil in treatment of tumor metastases and cancer
US6679870B1 (en) 1999-07-23 2004-01-20 Vasca, Inc. Methods and kits for locking and disinfecting implanted catheters
US6685694B2 (en) 1999-07-23 2004-02-03 Vasca, Inc. Methods and kits for locking and disinfecting implanted catheters
JP3213293B2 (ja) 1999-08-02 2001-10-02 本田技研工業株式会社 エンジン制御装置
DE60030770T2 (de) 1999-12-06 2007-09-06 Rhode Island Hospital Verwendung von taurolidin oder taurultam zur herstellung eines medikaments zur behandlung von ovarialkarzinomen
CN100519525C (zh) * 1999-12-06 2009-07-29 葛兰素集团有限公司 芳香砜类及其医疗用途
US20020004502A1 (en) * 2000-01-05 2002-01-10 Redmond H. Paul Treatment of inflammatory bowel disease
US6641571B2 (en) 2000-01-05 2003-11-04 Ed. Geistlich Soehne Ag Fuer Chemische Industrie Reduction of postoperative complications of cardiopulmonary bypass (CPB) surgery
EP1245247A1 (fr) 2001-03-28 2002-10-02 Biolink Corporation Ecluse d'un agent biocide
US20080171738A1 (en) * 2001-04-03 2008-07-17 Ed. Geistlich Soehne Ag Fuer Chemische Industrie Treatment of Breast Cancer
JP5280603B2 (ja) 2001-10-01 2013-09-04 ガイストリッヒ ファーマ アーゲー 転移阻害のための方法
US20050008684A1 (en) * 2003-07-10 2005-01-13 Claus Herdeis Method of treatment for acne, rosacea and ulcers with taurolidine and/or taurultam in a pharmaceutical composition
WO2005115357A2 (fr) * 2004-05-14 2005-12-08 Hans-Dietrich Polaschegg Formulations de taurolidine et administration: traitements thérapeutiques et protection antimicrobienne contre la formation de biofilm bactérien
US7696182B2 (en) 2004-11-02 2010-04-13 Nd Partners, Llc Antimicrobial locking solutions comprising taurinamide derivatives and biologically acceptable salts and acids, with the addition of small concentrations of heparin
RU2624846C1 (ru) * 2016-10-10 2017-07-07 федеральное государственное бюджетное учреждение "Федеральный научно-исследовательский центр эпидемиологии и микробиологии имени почетного академика Н.Ф. Гамалеи" Министерства здравоохранения Российской Федерации Применение 4-(3-этокси-4-гидроксибензил)-5-оксо-5,6-дигидро-4Н-[1,3,4]-тиадиазин-2-(2,4-дифторфенил)-карбоксамида для подавления инфекции, вызванной устойчивыми к антибиотикам штаммами Pseudomonas aeruginosa, и способ подавления этой инфекции
RU2737087C1 (ru) * 2020-03-20 2020-11-24 федеральное государственное бюджетное учреждение «Национальный исследовательский центр эпидемиологии и микробиологии имени почетного академика Н.Ф. Гамалеи» Министерства здравоохранения Российской Федерации Фармацевтическая композиция 4-(3-этокси-4-гидроксибензил)-5-оксо-5,6-дигидро-4h-[1,3,4]-тиадиазин-2-(2,4-дифторфенил)"карбоксамид в кристаллической форме, и ее применение в качестве антибактериального препарата для лечения острых, рецидивирующих и хронических инфекций
US11738120B1 (en) 2022-04-14 2023-08-29 Cormedix Inc. Synthesis of taurolidine, purity profiles and polymorphs

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1525296A (en) * 1975-08-04 1978-09-20 Geistlich Soehne Ag Antibacterial compositions
US4107305A (en) * 1975-08-04 1978-08-15 Ed. Geistlich Sohne A.G. Fur Chemische Industrie Treatment of endotoxaemia

Also Published As

Publication number Publication date
EP0139535A2 (fr) 1985-05-02
DE3483869D1 (de) 1991-02-07
AU3457384A (en) 1986-04-24
CH660970A5 (de) 1987-06-30
EP0139535B1 (fr) 1990-12-27
GB8328111D0 (en) 1983-11-23
EP0139535A3 (en) 1985-10-23
ATE59296T1 (de) 1991-01-15
US4626536A (en) 1986-12-02
IT1178154B (it) 1987-09-09
JPS60105618A (ja) 1985-06-11
DE3438469A1 (de) 1985-05-09
IT8449031A1 (it) 1986-04-18
IT8449031A0 (it) 1984-10-18

Similar Documents

Publication Publication Date Title
BE900856A (fr) Compositions pour combattre la toxemie.
BE900855A (fr) Compositions pour le traitement prophylactique de l'osteite et de l'osteomyelite.
TNSN96085A1 (fr) Amides therapeutiques et compositions les contenant
FR2708608A1 (fr) Dérivés de N-sulfonylbenzimidazolone, leur préparation, les compositions pharmaceutiques en contenant.
BE903183A (fr) Nouveaux derives du benzonorbornene, leurs procedes de preparation et composition medicamenteuse et cosmetique les contenant
BE1002211A4 (fr) (pentamethyl-1,2,2,6,6 piperidyl-4-amino)-triazines, leur application comme stabilisants de matieres organiques, et compositions qui en contiennent.
FR2636948A1 (fr) N-(2-piperidylmethyl)benzamides substitues anti-arythmiques et composition pharmaceutique les contenant
WO1979000853A1 (fr) Produit medicinal pour organe circulatoire
CA2216617A1 (fr) Nouveaux derives de flavones, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
FR2434802A1 (fr) Oxime-carbamates et carbonates utiles pour la protection des cultures
FR2436149A1 (fr) Nouveaux aminoglucosides, leur preparation et leur application comme medicaments
BE901987A (fr) Derives d'alcanolamines et inhibiteurs de l'agregation des plaquettes en contenant comme principe actif.
FR2636946A1 (fr) ((diarylmethoxy)alcoyl)-1 pyrrolidines et piperidines, procedes de preparation et medicaments les contenant
FR2455587A1 (fr) Derives de benzimidazole, leur preparation et utilisation dans le traitement des affections cardiovasculaires et compositions les contenant
DE3477488D1 (en) Polymethoxybenzyl piperazine derivatives, processes for their preparation and pharmaceutical compositions containing said derivatives
FR2426035A1 (fr) Composes de metaux de transition hexacoordonnes contenant au moins un substituant polyfluoroalcoyle et combustibles les contenant
MY102506A (en) Improvements in or relating to fungicides
AU539847B2 (en) 3,4,5-trihydroxypiperidine compounds
FR2453152A1 (fr) Nouveaux derives de prostaglandine et medicament les contenant
FR2372190A1 (fr) Composes organiques du silicium comprenant au moins un radical alcenyloxy et compositions thermodurcissables les contenant
FR2430937A1 (fr) Triiodo-benzonitriles et agents de diagnostic qui en contiennent
KR850001663A (ko) 살충 및 응애류 박멸제 조성물
BE1002181A3 (fr) 3-(2-haloalkyl)-1,4-oxathiines et 2-(2-haloalkyl)-1,4-dithiines, de meme que le traitement de la leucemie et des tumeurs avec ces substances.
FR2442236A1 (fr)
SE8702422D0 (sv) Improvements in or relating to fungicides

Legal Events

Date Code Title Description
RE Patent lapsed

Owner name: ED. GEISTLICH SOHNE A.G. FUR CHEMISCHE INDUSTRIE

Effective date: 19951031